6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Spinal Fractures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celli, M; Cipriani, C; Colangelo, L; Diacinti, D; Iannacone, A; Kripa, E; Minisola, S; Nieddu, L; Pepe, J; Pisani, D; Zambrano, A | 1 |
| Celli, L; Celli, M; D'Alfonso, Y; D'Eufemia, P; Febbo, A; Persiani, P; Turchetti, A; Zambrano, A | 1 |
2 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Spinal Fractures
| Article | Year |
|---|---|
Vertebral fracture assessment (VFA) for monitoring vertebral reshaping in children and adolescents with osteogenesis imperfecta treated with intravenous neridronate.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Child, Preschool; Diphosphonates; Female; Humans; Infant; Male; Osteogenesis Imperfecta; Spinal Fractures | 2021 |
Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
Topics: Adolescent; Bone Density Conservation Agents; Diphosphonates; Humans; Low Density Lipoprotein Receptor-Related Protein-5; Male; Mutation; Osteogenesis Imperfecta; Osteoporotic Fractures; Radiography; Spinal Fractures | 2017 |